Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease

Pharmacology, Biochemistry, and Behavior
Glenda E GilliesSimon McArthur

Abstract

The incidence of certain neurological disorders, including Parkinson's disease, appears to be more prevalent in men. Studies involving estrogen treatment of ovariectomised rodents attribute this largely to the neuroprotective effects of estrogen. However, a neuroprotective role for physiological levels of circulating hormones in males and females is less clear. Using the 6-hydroxydopamine (6-OHDA) model of Parkinson's disease to lesion the nigrostriatal dopaminergic (NSDA) pathway, we have shown that in females, endogenously produced estrogen is neuroprotective, whereas in males, gonadal factors increase striatal 6-OHDA toxicity. Intriguingly, estrogen, but not dihydrotestosterone, a nonaromatizable androgen, reversed the effects of orchidectomy on lesion size, raising the novel the hypothesis that enhanced male susceptibility may be attributable to the effects of endogenous testosterone only after its aromatization to estrogen. Thus, estrogen appears to exert opposite effects in the NSDA in males and females, being neuroprotective in females, but not in males, where it may even exacerbate neurodegenerative responses, with important implications for the clinical potential of estrogen-related compounds as neuroprotective agents....Continue Reading

References

Jan 1, 1994·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·Y L Yu, G C Wagner
Jan 1, 1993·Journal of Neural Transmission. General Section·G C WagnerC T Cheo
Mar 21, 1998·Schizophrenia Bulletin·H HäfnerA Stein
Jul 21, 1998·Annals of the New York Academy of Sciences·D B MillerS C Laws
Nov 11, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D B DubalP M Wise
Feb 11, 2000·Annals of the New York Academy of Sciences·A C Scallet
Apr 25, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P D Hurn, I M Macrae
Jul 6, 2000·Neuroscience·D I FinkelsteinM K Horne
Jan 6, 2001·Neuron·D A Lewis, J A Lieberman
Mar 15, 2001·Parkinsonism & Related Disorders·R H. SwerdlowG F. Wooten
Nov 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·David Cotter, Carmine M Pariante

❮ Previous
Next ❯

Citations

Dec 30, 2006·Biochemical and Biophysical Research Communications·Hao ZhangQinong Ye
Dec 14, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Simon McArthurGlenda E Gillies
Dec 8, 2007·American Journal of Respiratory Cell and Molecular Biology·Shigeki MatsubaraErwin W Gelfand
Mar 3, 2006·The Journal of Clinical Investigation·Bonnie J Deroo, Kenneth S Korach
Apr 24, 2008·Genetics·Jane P Kenney-HuntJames M Cheverud
Apr 17, 2008·The European Journal of Neuroscience·Lori K SmithGerlinde A Metz
Oct 1, 2011·Hormone Molecular Biology and Clinical Investigation·Roberto Cosimo Melcangi, Luis M Garcia-Segura
Sep 13, 2011·Hormones and Behavior·Rebecca L CunninghamAndrea Giuffrida
Mar 13, 2014·Frontiers in Neuroendocrinology·Glenda E GilliesZahi Qamhawi
Jun 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Roberta FrigerioWalter A Rocca
Feb 1, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Roberta FrigerioWalter A Rocca
Jan 21, 2018·Biology of Sex Differences·Marzia PesaresiRoberto Cosimo Melcangi
May 22, 2009·Journal of Neurochemistry·Susanne Arnold, Cordian Beyer
Feb 9, 2010·Journal of Neuroendocrinology·M L JohnsonC M Kuhn
Jun 19, 2010·CNS Neuroscience & Therapeutics·Maria Gabriela SánchezThérèse Di Paolo
Mar 26, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Briana R De MirandaJ Timothy Greenamyre
Oct 12, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Kaja KolmancicMaja Kojovic
Sep 24, 2019·Endocrine Reviews·Elisabetta VegetoAngelo Poletti
Sep 17, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Benjamin Meir JacobsAlastair J Noyce
Aug 15, 2018·Brain Sciences·Paulo Pinares-GarciaJoohyung Lee
Jul 14, 2010·Annals of Neurology·Donald L BliwiseDavid B Rye
Jan 16, 2021·European Journal of Pharmacology·Bhupesh VaidyaShyam Sunder Sharma
Feb 14, 2021·Brain Structure & Function·Anne C TruttiBirte U Forstmann
Jan 8, 2021·Environmental Science and Pollution Research International·Mustafa Makav, Hüseyin Avni Eroğlu
Jun 13, 2012·Hormones and Behavior·Rodolfo SavicaWalter A Rocca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.